診療所における体外診断（IVD）検査市場

当レポートでは、世界の診療所における体外診断（IVD）検査市場について調査し、市場の概要とともに、市場の環境、診療所におけるIVD製品の用途、地域別市場、および市場に参入する企業のプロファイルなどを提供しています。

当レポートは、医師事務作業室で使用される体外診断用医薬品（IVD）製品の世界の需要動向を分析したものです。具体的な製品は、試薬、検査キット、標準品、対照品、免疫測定、臨床化学、血液学、分子生物学、微生物学、凝固学などの技術に基づく機器やシステムで構成されています。医師のオフィスラボは、1人以上の医師がいる従来の診療所や緊急医療センター内のポイントオブケア（POC）検査施設と定義されています。これらの検査室のほとんどは、迅速な診断結果を得るために、1つまたは複数の携帯型デスクトップ機器を使ってIVD検査を実施しています。

本レポートに掲載されている情報およびデータは以下の通りです：

• 製品の需要パターンと成長機会に影響を与えるマクロ経済、人口統計、疫学、ヘルスケア指標
• 2022年から2027年までの世界の製品タイプ別および技術別の需要予測
• 各予測年（2022年～2027年）における医師事務作業用IVD製品の地域および特定国の市場予測値

また、医師事務作業用IVD製品の主要生産者のプロファイルも掲載しています。

レポート対象は世界市場に及びますが、米国とその他の先進国に焦点をあてています。発展途上国の医師事務作業所の大部分は病院や外来診療所にあり、患者の検査には積極的に取り組んでいません。

また、本レポートでは、以下のような市場の主要企業のプロファイルを掲載しています：

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場環境

• 概要
• 世界経済の見通し
• 人口
• 世界のヘルスケア動向

第4章 診療所検査室用（POL）IVD製品

• 概要
• IVD業界の動向
• IVD技術
• 免疫学的検査
• 臨床化学
• 分子IVD技術
• 微生物学
• 血液学
• 凝固
• 組織学/細胞学
• 血液型
• その他のIVD技術
• 業界規制
• ポイントオブケア（POC）検査市場
• 診療所におけるPOC検査：市場概要
• POL検査の用途
• POL IVD製品のタイプ別売上高

第5章 地域別市場

• 概要
• 米国
• カナダ
• メキシコ
• ドイツ
• フランス
• 英国
• イタリア
• スペイン
• その他の西欧
• 中国
• インド
• 日本
• 韓国
• オーストラリア
• その他のアジア太平洋
• 中南米
• 東欧
• アフリカ/中東

第6章 企業プロファイル

• 概要
• Abbott Laboratories
• Abingdon Health
• ACON Laboratories, Inc.
• ArcDia International Oy Ltd.
• Axis-Shield Diagnostics Ltd.
• Becton Dickinson and Company (BD)
• binx health, inc.
• Bio-Rad Laboratories, Inc.
• Biocartis NV
• Biomerica, Inc.
• bioMerieux S.A.
• Boule Diagnostics AB
• Cardinal Health, Inc.
• Carolina Liquid Chemistries Corporation
• Chembio Diagnostics, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• DiaSys Diagnostic Systems GmbH
• Diazyme Laboratories, Inc.
• EKF Diagnostics Holdings plc
• Exact Sciences Corporation
• genedrive plc
• HORIBA Ltd.
• Immunostics, Inc.
• MedMira, Inc.
• Meridian Bioscience, Inc.
• OraSure Technologies
• PTS Diagnostics
• QuantuMDx Group Ltd.
• QuidelOrtho Corporation
• Roche
• Siemens Healthcare GmbH
• Stago Group
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Trinity Biotech plc
• Werfen

This report analyzes trends in global demand for in vitro diagnostic (IVD) products used in physicians' office laboratories. Specific products consist of reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies. Physicians' office laboratories are defined as point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. Most of these laboratories implement IVD procedures through one or more portable desktop instruments that yield rapid diagnostic results.

Information and data appearing in this report include:

• Macroeconomic, demographic, epidemiological, and healthcare indicators that influence product demand patterns and growth opportunities

• Projected global product demand by type and technology for the years 2022 through 2027

• The projected value of regional and selected national markets for physicians' office laboratory IVD products in each of the forecast years (2022 through 2027).

The report also includes profiles of the major producers of physicians' office laboratory IVD products.

Report coverage extends to worldwide markets, but focuses on the United States and other developed countries. The majority of physicians' practices in the developing world are located in hospitals and outpatient clinics and do not engage actively in patient testing.

In addition, the report profiles key companies in the market, including:

Table of Contents

Chapter 1: Introduction

• Scope & Report Coverage
• Methodology
• Size and Growth of Market
  • Figure 1-1: Physician Office Labs Market, 2022-2027
• Opportunity For Growth in Non-COVID Testing
  • Figure 1-2: Growth in the POL Market w /COVID-19 excluded, 2022-2027
• Sources of Information
• Urgent Care Centers
  • Figure 1-3: Urgent Care Center Market, 2022-2027 ($ million)

Chapter 2: Executive Summary

• Physicians' Office Laboratories: Market Overview
• Product Demand Patterns
• Geographical Markets
• Size and Growth of the Market
  • Table 2-1: Summary Table: Global Physicians' Office Laboratory Market, 2022-2027 (million dollars)

Chapter 3: Market Environment

• Overview
• Global Economic Outlook
• Gross Domestic Product
  • Table 3-1: Gross Domestic Product by Country/Region, 2022-2027 (billion dollars)
• Per Capita Gross Domestic Product
  • Table 3-2: Per Capita Gross Domestic Product by Country/Region, 2022-2027 (dollars)
• Population
  • Table 3-3: Population by Country/Region, 2022-2027 (million persons)
• Age Distribution
• Population 50 Years & Older
  • Table 3-4: Population 50 Years & Older by Country/Region, 2022-2027 (million persons)
  • Table 3-5: Percentage of Population 50 Years & Older by Country/Region, 2022-2027 (million persons)
• Population 65 Years & Older
  • Table 3-6: Population 65 Years & Older by Country/Region, 2022-2027 (million persons)
  • Table 3-7: Percentage of Population 65 Years & Older by Country/Region, 2022-2027 (million persons)
• Global Healthcare Trends
• Medical Conditions
• Health Expenditures
  • Table 3-8: Health Expenditures by Country/Region, 2022-2027 (billion dollars)
  • Table 3-9: Per Capita Health Expenditures by Country/Region, 2022-2027 (dollars)
• Hospital Beds
  • Table 3-10: Number of Acute Care Hospital Beds by Country/Region, 2022-2027 (thousands)
  • Table 3-11: Number of Hospital Beds Per 1,000 Capita by Country/Region, 2022-2027
• Physicians
  • Table 3-12: Number of Practicing Physicians by Country/Region, 2022-2027 (thousands)
  • Table 3-13: Number of Practicing Physicians Per 1,000 Capita by Country/Region, 2022-2027
• Patient Activity
• Acute Care Hospital Admissions
  • Table 3-14: Number of Acute Care Hospital Admissions by Country/Region, 2022-2027 (thousands)
  • Table 3-15: Number of Acute Care Hospital Admissions Per 1,000 Capita by Country/Region, 2022-2027
• Surgical Procedures
  • Table 3-16: Number of Surgical Procedures by Country/Region, 2022-2027 (thousands)
  • Table 3-17: Number of Surgical Procedures Per 1,000 Capita by Country/Region, 2022-2027
• Physicians' Consultations
  • Table 3-18: Number of Physicians' Consultations by Country/Region, 2022-2027 (millions)
  • Table 3-19: Number of Physicians' Consultations Per Capita by Country/Region, 2022-2027
• IVD Tests
  • Table 3-20: Number of IVD Tests by Country/Region, 2022-2027 (millions)
  • Table 3-21: Number of IVD Tests Per Capita by Country/Region, 2022-2027
• Traditional Physicians' Offices
  • Table 3-22: Number of Traditional Physicians' Offices by Country/Region, 2022-2027 (thousands)
• Urgent Care Centers
  • Table 3-23: Number of Urgent Care Centers by Country/Region, 2022-2027
• Physicians' Office Laboratories
  • Table 3-24: Number of Physicians' Office Laboratories by Country/Region, 2022-2027 (thousands)

Chapter 4: Physicians' Office Laboratory (POL) IVD Products

• Overview
• IVD Industry Trends
  • Table 4-1: Global IVD Product Demand by Technology & Segment, 2022-2027 (million dollars)
• IVD Technologies
• Immunoassays
• Clinical Chemistry
• Molecular IVD Technology
• Microbiology
• Hematology
• Coagulation
• Histology/Cytology
• Blood Grouping
• Other IVD Technologies
• Industry Regulations
• Point-of-Care (POC) Testing Market
  • Table 4-2: Global Point-of-Care IVD Product Sales, 2022-2027 (million dollars)
• Physicians' Office POC Testing: Market Overview
  • Table 4-3: Global Physicians' Office Laboratory Total IVD Sales (with COVID-19 products) by Type of Establishment, 2022-2027 (million dollars)
  • Table 4-4: Global Physicians' Office Laboratory Total IVD Sales (excluding COVID-19 products) by Type of Establishment, 2022-2027 (million dollars)
• POL Testing Applications
  • Table 4-5: Total Physicians' Office Laboratory Global IVD Sales by Application, 2022-2027 (million dollars)
  • Table 4-6: Traditional Physicians' Office Laboratories Global IVD Sales by Application, 2022-2027 (million dollars)
  • Table 4-7: Urgent Care Center Laboratories Global IVD Sales by Application, 2022-2027 (million dollars)
• Infectious Disease POL Tests
• COVID-19 POL Tests
  • Table 4-8: Global POL COVID-19 IVD Product Sales, 2022-2027 (million dollars)
• Other Infectious Disease POL Tests
  • Table 4-9: Global POL Other Infectious Disease IVD Product Sales, 2022-2027 (million dollars)
• Colon Cancer POL Tests
  • Table 4-10: Global POL Colon Cancer IVD Product Sales, 2022-2027 (million dollars)
• Glucose POL Tests
  • Table 4-11: Global POL Glucose IVD Product Sales, 2022-2027 (million dollars)
• Drugs of Abuse POL Tests
  • Table 4-12: Global POL Drugs of Abuse IVD Product Sales, 2022-2027 (million dollars)
• Blood Gas & Electrolyte POL Tests
  • Table 4-13: Global POL Blood Gas & Electrolyte IVD Product Sales, 2022-2027 (million dollars)
• Coagulation POL Tests
  • Table 4-14: Global POL Coagulation IVD Product Sales, 2022-2027 (million dollars)
• Cardiac Marker POL Tests
  • Table 4-15: Global POL Cardiac Marker IVD Product Sales, 2022-2027 (million dollars)
• Hematology POL Tests
  • Table 4-16: Global POL Hematology IVD Product Sales, 2022-2027 (million dollars)
• HbA1c POL Tests
  • Table 4-17: Global POL HbA1c IVD Product Sales, 2022-2027 (million dollars)
• Cholesterol POL Tests
  • Table 4-18: Global POL Cholesterol IVD Product Sales, 2022-2027 (million dollars)
• Pregnancy/Infertility POL Tests
  • Table 4-19: Global POL Pregnancy/Infertility IVD Product Sales, 2022-2027 (million dollars)
• Cancer Marker POL Tests
  • Table 4-20: Global POL Cancer Marker IVD Product Sales, 2022-2027 (million dollars)
• Urinalysis POL Tests
  • Table 4-21: Global POL Urinalysis IVD Product Sales, 2022-2027 (million dollars)
• Other POL Tests
  • Table 4-22: Global POL Other IVD Product Sales, 2022-2027 (million dollars)
• POL IVD Product Sales by Type
  • Table 4-24: Global POL IVD Product Sales by Type, 2022-2027 (million dollars)

Chapter 5: Geographical Markets

• Overview
• United States
• Canada
• Mexico
• Germany
• France
• United Kingdom
• Italy
• Spain
• Other Western Europe
• China
• India
• Japan
• South Korea
• Australia
• Other Asia/Pacific
• Central & South America
• Eastern Europe
• Africa/Mideast

Chapter 6: Company Profiles

• Overview
  • Table 6-1: Global POL Testing Revenues and Market Share of Leading Suppliers, 2022 (in millions $)

• Abbott Laboratories
• Abingdon Health
• ACON Laboratories, Inc.
• ArcDia International Oy Ltd.
• Axis-Shield Diagnostics Ltd.
• Becton Dickinson and Company (BD)
• binx health, inc.
• Bio-Rad Laboratories, Inc.
• Biocartis NV
• Biomerica, Inc.
• bioMerieux S.A.
• Boule Diagnostics AB
• Cardinal Health, Inc.
• Carolina Liquid Chemistries Corporation
• Chembio Diagnostics, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• DiaSys Diagnostic Systems GmbH
• Diazyme Laboratories, Inc.
• EKF Diagnostics Holdings plc
• Exact Sciences Corporation
• genedrive plc
• HORIBA Ltd.
• Immunostics, Inc.
• MedMira, Inc.
• Meridian Bioscience, Inc.
• OraSure Technologies
• PTS Diagnostics
• QuantuMDx Group Ltd.
• QuidelOrtho Corporation
• Roche
• Siemens Healthcare GmbH (Siemens Healthineers)
• Stago Group
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Trinity Biotech plc
• Werfen